Navigation Links
ResMed to Webcast First Quarter 2009 Earnings Conference Call
Date:10/23/2008

SAN DIEGO, Oct. 23 /PRNewswire-FirstCall/ -- RESMED INC. (NYSE: RMD), announced today that on Thursday, November 6, 2008, it will release its earnings for the first quarter of fiscal year 2009, ended September 30, 2008. ResMed will issue an earnings press release after 1:00 p.m. Pacific Time and will host a conference call to review its quarterly results, market trends, and future outlook.

The conference call is scheduled to begin at 1:30 p.m. Pacific Time and will be webcast on ResMed's website at http://www.resmed.com. The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be:

9:30 p.m. London

8:30 a.m. Sydney, Australia (November 7, 2008)

TO PARTICIPATE in the conference call, please call one of the below numbers at least 10 minutes before the call begins and identify yourself to the operator:

Domestic: 800-261-3417

International: 617-614-3673

Conference Name: ResMed Inc. 1Q 2009 Earnings Call

Participant Passcode: 49480223

The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:

Domestic: 888-286-8010

International: 617-801-6888

Passcode: 99471059

ResMed is a leading manufacturer of medical equipment for the treatment and management of sleep-disordered breathing and other respiratory disorders. Further information can be obtained by contacting Matthew Borer at ResMed I
'/>"/>

SOURCE ResMed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ResMed to Webcast Third Quarter 2008 Earnings Conference Call
2. RESMED to Webcast Second Quarter 2008 Earnings Conference Call
3. ResMed to Webcast First Quarter 2008 Earnings Conference Call
4. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
5. Rigel to Webcast Investor Update on October 27, 2008
6. MiddleBrook to Webcast Management Presentation at the 10th Annual Rodman & Renshaw Healthcare Conference
7. Gen-Probe Announces Webcasts of Three Upcoming Investor Events
8. RAI to Webcast Third-Quarter 2008 Earnings Conference Call
9. New Webcast Going for Gold to Educate on Importance of Healthy Diet In Persistent Chronic Pain Management
10. MannKind Corporation to Host Webcast Analyst Day September 16, 2008
11. PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Philadelphia, PA, October 1, 2014 Patients with ... treatment, have a greatly increased risk of depression. ... therapy for chronic hepatitis C virus infection causes ... Omega-3 fatty acids, more commonly known as fish ... including lowering the risk of heart disease and ...
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new blog post explaining ... , Senior citizens can purchase a joint life insurance ... A joint policy is cheaper, but will only pay ... Life insurance can be used to cover important funeral ... online, as the application process is simple and straightforward. ...
(Date:10/1/2014)... First Warning Systems, a pioneer in ... throughout the body, announced the company is changing its ... company’s breadth of upcoming product releases. The initial focus ... , “Our initial focus will be an ‘Internet of ... circadian cellular changes over time,” said Rob Royea, president ...
(Date:10/1/2014)... 01, 2014 Join the more than 80 ... Treatment Center’s first ever charity golf tournament to benefit Project ... eating disorders who cannot afford treatment. The tournament will be ... Eureka, Mo. , The day-long event starts with 10:30 ... and award dinner will begin at 5 p.m. and will ...
(Date:10/1/2014)... 2014 Innovations announces the upcoming airing ... on Monday, October 20, 2014 at 7:30 a.m. EST/PT ... go behind the scenes to learn about Break the ... explore the practical help and information Break the Cycle ... warning signs of abuse, how to navigate the legal ...
Breaking Medicine News(10 mins):Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2
... helps people who cannot swallow because of paralysis. Swallowing is ... of the cranial nerves. One of these, the vagal nerve, ... tract// - that is, above the esophagus, but below the ... to the lungs, and swallowing difficulties may occur. ...
... a huge men population, which evaluated more than 14,000 sperm ... reducing their numbers as well as their crucial ability to ... as the ozone level went up, the sperm concentration went ... and obstetrics and gynecology at the University of Southern California's ...
... long-awaited treatment for lymphoma - a drug that uses ... cells. Idec Pharmaceuticals' Zevalin becomes the first radioimmunotherapy drug ... ,It's a new approach, adding radiation to antibodies that ... cells. The antibodies attach to the cells, flagging them ...
... that helps form blood clots, may also be involved in ... to new strategies for repairing diseases of the nervous system, ... on the basic science level.// ,In multiple sclerosis, the ... fibers in the brain and spine can lead to numbness, ...
... According to a new study, filtering out the antibodies that ... with live donor transplants. Many patients need a kidney transplant ... found. Body organs, from dead bodies, are in short supply, ... they must be of a compatible blood group. ...
... the symptoms of Lyme disease linger despite antibiotic treatment.,Lyme ... ticks, sometimes produces very long-lasting fatigue and cognitive problems. ... feel that this treatment would not be enough to ... Lyme patients, some of whom were assigned to the ...
Cached Medicine News:Health News:Elevated Ozone Levels Hurt Sperm Count 2Health News:Clotting Protein plays a role in nerve repair 2
(Date:10/1/2014)... ANDOVER, Mass. , Oct. 1, 2014 /PRNewswire/ ... ; AEX: PHIA) today announced its eCareCoordinator and ... the U.S. Food and Drug Administration (FDA). A ... of telehealth programs , eCareCoordinator and eCareCompanion are ... are the first clinical applications to be available ...
(Date:10/1/2014)... 2014 Ardelyx, Inc. (NASDAQ: ... focused on cardio-renal, gastrointestinal and metabolic diseases, ... patient Phase 2b clinical trial evaluating tenapanor ... (IBS-C).  Results from this study demonstrated statistically ... symptoms for tenapanor-treated patients compared to patients ...
(Date:10/1/2014)... 1, 2014 Sophia Genetics, ... domaine de l,analyse des données issues du SNG ... de diagnostic in vitro (IVD) du gène CFTR ... la mucoviscidose dans un seul essai SGN. La ... les types de variantes par l,intermédiaire d,un seul ...
Breaking Medicine Technology:Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 3Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3
... Calif., Sept. 19, 2011 Amgen (NASDAQ: ... Drug Administration (FDA) approved two new indications for Prolia® ... women at high risk for fracture receiving adjuvant aromatase ... to increase bone mass in men at high risk ...
... Sept. 19, 2011 Boston Scientific Corporation (NYSE: ... a highly deliverable and ultra-low profile 0.014 inch balloon ... procedures below the knee.  The Company has begun marketing ... markets.   Boston Scientific developed the Coyote ...
Cached Medicine Technology:FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy 2FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy 3FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy 4FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy 5FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy 6FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy 7FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy 8Boston Scientific Launches Coyote™ Balloon Catheter 2Boston Scientific Launches Coyote™ Balloon Catheter 3Boston Scientific Launches Coyote™ Balloon Catheter 4
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Cordis DUCOR Catheters are available in a broad variety of French sizes and configurations. These catheters combine an atraumatic tip with either a braided or non-braided body....
Coronary angiographic catheter...
Leksell Neuro Generator is a complete system for stereotactic lesioning, pain treatment, stimulation and bipolar coagulation. It features a radio frequency (RF) energy source with sophisticated, inte...
Medicine Products: